Binding of toxic shock syndrome toxin‐1 to murine major histocompatibility complex class II molecules
- 1 September 1990
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 20 (9) , 1911-1916
- https://doi.org/10.1002/eji.1830200907
Abstract
The staphylococcal exotoxin toxic shock syndrome toxin-1 (TSST-1) has potent stimulatory effects on murine and human lymphocytes. This is the consequence of TSST-1 binding to major histocompatibility complex (MHC) class II molecules and the engagement in a Vβ-restricted fashion of the T cell receptor by the TSST-1-MHC class II complex. Using radioligand and functional assays we have recently shown that TSST-1 binds to all HLA-DR (n = 14), HLA-DQ (n = 2) and HLA-DP (n = 2) phenotypes tested. In this study, we have examined the ability of murine MHC class II molecules to bind TSST-1. Specific high-affinity binding of TSST-1 was detectable to unfractionated BALB-c (H-2d) and C57BL/6 (H-2b), but not to C3H (H-2k) spleen cells. The Kd of this binding estimated from Scatchard analysis was in the same nanomolar range as the Kd of binding of TSST-1 to HLA-DR. Binding of 125I-labeled TSST-1 to BALB/c-derived B cell lymphoma lines and to L cell transfectants correlated with the expression of I-A molecules, but not with the expression of I-E molecules. Furthermore, I-A+, I-E− cells but not I-A−, I-E+ cells were able to support TSST-1-induced T cell proliferation. The binding affinity of TSST-1 for I-Ak appears to be much lower than for I-Ad. L cell transfectants expressing hybrid DRα: I-E molecules, but not those expressing I-E: DR1β molecules, could bind TSST-1 and efficiently support TSST-1-induced T cell proliferation. This suggests that minor differences in the highly homologous I-Eα and DRα chains are critical in determining the affinity of the MHC class II molecule for TSST-1. These results demonstrate that the binding of TSST-1 to MHC class II molecules in the mouse, in contrast to humans, is strongly influenced by phenotype. Analysis of the molecular basis of these differences may help to localize staphylococcal exotoxin binding sites on MHC class II molecules.This publication has 34 references indexed in Scilit:
- The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.The Journal of Experimental Medicine, 1989
- The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal miceCell, 1989
- Production of Tumor Necrosis Factor by Human Monocytes in Response to Toxic-Shock-Syndrome Toxin-1The Journal of Infectious Diseases, 1988
- Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules.The Journal of Experimental Medicine, 1988
- STAPHYLOCOCCAL ENTEROTOXIN B STIMULATION OF BALB/c LYMPHOCYTE MITOGENESIS AND POTENTIAL RELATIONSHIP TO THE Mls RESPONSEInternational Journal of Immunogenetics, 1988
- Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferationClinical Immunology and Immunopathology, 1987
- Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome.Journal of Clinical Investigation, 1984
- A NEW STAPHYLOCOCCAL ENTEROTOXIN, ENTEROTOXIN F, ASSOCIATED WITH TOXIC-SHOCK-SYNDROME STAPHYLOCOCCUS AUREUS ISOLATESThe Lancet, 1981
- Identification and Characterization of an Exotoxin from Staphylococcus aureus Associated with Toxic-Shock SyndromeThe Journal of Infectious Diseases, 1981
- Toxic-Shock SyndromeNew England Journal of Medicine, 1980